There is no clear evidence of an increased risk for myocardial infarction, stroke, or other cardiovascular events associated with the use of entacapone for the treatment of Parkinson's disease (PD), a ...

Company states the realisation of generic competition is still neither certain nor imminent Orion Corporation has been informed that Sun Pharma Global, Inc. has filed an Abbreviated New Drug ...

Mylan Inc. said Thursday that it had reached an agreement to settle patent litigation over the generic version of Orion Corp.'s Comtan. Mylan Inc. said Thursday that it had reached an agreement to ...

CHICAGO (Reuters) - Drugs used to treat Parkinson's disease show promise as a new way to stem the rise of drug-resistant forms of tuberculosis, U.S. researchers said on Thursday. They said computer ...

Drug firm Wockhardt on Monday said it will launch a generic version of Finnish company Orion Corporation's Comtan tablets, used in treating Parkinson's disease, in the US with 180 days of marketing ...

Wockhardt has got USFDA nod for generic version of Comtan, reports CNBC-TV18. The share touched a 52-week high of Rs 1,325. At 09:24 hrs the share was quoting at Rs 1,318.00, up Rs 19.35, or 1.49%.

* Drugs could be used to fight dangerous forms of TB * Compounds already proven in humans By Julie Steenhuysen CHICAGO, July 2 (Reuters) - Drugs used to treat Parkinson's disease show promise as a new ...